• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Office of Drug Evaluation III (ODE III)


The Office of Drug Evaluation III is responsible for protecting the public health by assuring safe and effective drugs and biologics are available to the U.S. population for dermatology, dental, gastroenterology, reproductive, and urologic uses and for in-born-errors of metabolism and conditions involving bone metabolism.

Immediate Office

Director: Julie Beitz, M.D.
Deputy Director: Vacant

Associate Director For Regulatory Affairs: Maria R. Walsh, R.N., M.S.
Regulatory Scientist: Giuseppe Randazzo, M.S.
Program Support Specialist: Diane Thomas



Mailing Address:
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Drug Evaluation III
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2100
Fax: (301) 796-9906